Brian Alexander, Foundation Medicine CEO (LinkedIn)

Bris­tol My­ers, Foun­da­tion Med­i­cine ex­pand col­lab­o­ra­tion to ex-Turn­ing Point can­cer drug

Roche sub­sidiary Foun­da­tion Med­i­cine has ex­pand­ed a Big Phar­ma col­lab­o­ra­tion around its com­pan­ion di­ag­nos­tic and a po­ten­tial fu­ture block­buster.

The di­ag­nos­tics out­fit put out word …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.